Department of Anesthesiology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
CNS Drugs. 2022 Aug;36(8):877-896. doi: 10.1007/s40263-022-00936-y. Epub 2022 Jul 15.
Neuraxial drug administration, i.e., the injection of drugs into the epidural or intrathecal space to produce anesthesia or analgesia, is a technique developed more than 120 years ago. Today, it still is widely used in daily practice in anesthesiology and in acute and chronic pain therapy. A multitude of different drugs have been introduced for neuraxial injection, only a part of which have obtained official approval for that indication. A broad understanding of the pharmacology of those agents is essential to the clinician to utilize them in a safe and efficient manner. In the present narrative review, we summarize current knowledge on neuraxial anatomy relevant to clinical practice, including pediatric anatomy. Then, we delineate the general pharmacology of neuraxial drug administration, with particular attention to specific aspects of epidural and intrathecal pharmacokinetics and pharmacodynamics. Furthermore, we describe the most common clinical indications for neuraxial drug administration, including the perioperative setting, obstetrics, and chronic pain. Then, we discuss possible neurotoxic effects of neuraxial drugs, and moreover, we detail the specific properties of the most commonly used neuraxial drugs that are relevant to clinicians who employ epidural or intrathecal drug administration, in order to ensure adequate treatment and patient safety in these techniques. Finally, we give a brief overview on new developments in neuraxial drug therapy.
椎管内给药,即向硬膜外或蛛网膜下腔注射药物以产生麻醉或镇痛效果,是一种 120 多年前发展起来的技术。如今,它在麻醉学和急慢性疼痛治疗的日常实践中仍然广泛应用。已经有许多不同的药物被用于椎管内注射,其中只有一部分药物获得了该适应症的官方批准。临床医生必须广泛了解这些药物的药理学知识,才能以安全有效的方式使用它们。在本叙述性综述中,我们总结了与临床实践相关的椎管内解剖学的最新知识,包括儿科解剖学。然后,我们阐述了椎管内给药的一般药理学,特别关注硬膜外和蛛网膜下腔药代动力学和药效动力学的特定方面。此外,我们描述了椎管内给药的最常见临床适应症,包括围手术期、产科和慢性疼痛。然后,我们讨论了椎管内药物可能产生的神经毒性作用,此外,我们详细介绍了最常用的椎管内药物的特定性质,这些性质与使用硬膜外或蛛网膜下腔药物给药的临床医生有关,以确保这些技术中治疗的充分性和患者的安全性。最后,我们简要概述了椎管内药物治疗的新进展。